by telrheum | May 27, 2024 | Autoimmune Diseases, Biologic Therapy, IgG4-Related Diseases, JAK Inhibitor
The article “Successful Treatment of Refractory IgG4-Related Disease with Tofacitinib: Experiences from 7 Patients” presents a study conducted at Peking University People’s Hospital. The study aimed to evaluate the effectiveness and safety of tofacitinib, a Janus...
by telrheum | May 25, 2024 | IgG4-Related Diseases, Low Complements
Background IgG4-related disease (IgG4-RD) is an autoimmune condition that can affect various organs. Some patients with IgG4-RD have low levels of complement proteins in their blood. This study aimed to compare the characteristics and disease activity of IgG4-RD...
by telrheum | May 19, 2024 | Autoimmune Diseases, Biologic Therapy, Pneumocystis Jirovecii
This systematic review and meta-analysis led by Athanasios Vassilopoulos and colleagues focuses on the effectiveness of prophylactic Trimethoprim-Sulfamethoxazole (TMP/SMX) in preventing Pneumocystis Jirovecii Pneumonia (PJP) among patients with Autoimmune...
by telrheum | May 17, 2024 | Hydroxychloroquine, Autoimmune Diseases
The article titled “The Prevalence and Risk Factors of Retinal Toxicity Associated with Long-term Hydroxychloroquine Use” by Sophie Do and colleagues from Kaiser SCAL, Fontana, CA, explores the eye-related side effects of hydroxychloroquine (HCQ), a...
by telrheum | May 10, 2024 | Autoimmune Diseases, Infections, Viral Infections
The article “Long Covid in Persons with Self-Reported Arthritis – Symptoms, Associated Factors and Functional Limitations” by Debbie Ehrmann Feldman and Barbara Mazer explores the impact of long Covid on individuals with arthritis. Presented at ACR...
by telrheum | May 1, 2024 | Autoimmune Diseases, Stress
The article, “Stressful Life Events in the Year Prior to Their Diagnosis Are Associated with Adult and Pediatric Systemic Rheumatic Diseases,” investigates how stressful life events impact the likelihood of developing systemic rheumatic diseases (SRDs),...
